Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
featured
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients with Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medications

To assess the efficacy of miricorilant compared with placebo in reversing recent antipsychoticinduced weight gain (AIWG)  

  • 45 views
  • 23 Nov, 2020
  • 1 location
featured
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.

This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.  

antipsychotics
schizophrenia disorders
  • 22 views
  • 22 Dec, 2020
  • 1 location
featured
Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia

Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia

  • 220 views
  • 23 Nov, 2020
  • 1 location
featured
Study to Evaluate an Investigational Drug in Patients With Schizophrenia on Stable Antipsychotic Treatment

Study to Evaluate an Investigational Drug in Patients With Schizophrenia on Stable Antipsychotic Treatment

  • 244 views
  • 23 Nov, 2020
  • 1 location
a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics

This study is a pilot phased interventional clinical trial . The first stage will recruit 10 patients with antipsychotic induced extrapyramidal symptoms.The patients will take pramipexole for 8 weeks. The inital dose of pramipexole will be 0.375 mg/d, and the adjustment of drug dose will be depended on the the …

  • 0 views
  • 23 Jan, 2021
  • 1 location
R33: Levetiracetam in Early Psychosis

This is a 12 week study of Levetiracetam in conjunction with a second generation antipsychotic in medication-free first episode psychosis participants. Treatment with antipsychotics has been

  • 0 views
  • 26 Jan, 2021
  • 1 location
Tolerability Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

syndrome), currently treated with atypical antipsychotics. Patient Population: The intention is to treat 45 patients diagnosed with schizophrenia, who are currently suffering mainly from

antipsychotics
cognitive deficits
  • 0 views
  • 07 Nov, 2020
  • 1 location
The Effect of Guanfacine on Delirium in Critically Ill Patients

cost, increased ventilator days, and long-term cognitive disability. Various pharmacologic agents including dopamine antagonists, acetylcholinesterase inhibitors, melatonin, antipsychotics, alpha-2

  • 0 views
  • 26 Jan, 2021
  • 1 location
Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

The aim of the present study was to investigate the efficacy of aripiprazole in management of pre-existing neuroleptic-induced tardive dyskinesia

  • 53 views
  • 07 Nov, 2020
  • 1 location
SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

Parkinson's disease is often characterised by movement symptoms such as rigidity and bradykinesia, however, there are a number of non-motor symptoms that can have a significant impact on quality of life. One of the most common non-motor symptoms of Parkinson's disease is visual hallucinations (where someone sees things that don't …

  • 8 views
  • 24 Jan, 2021
  • 1 location